Webinar

Unlock payer market research opportunities with Cencora: What to expect and how to get started

Tuesday, June 9, 2026 | 2:00pm - 3:00pm ET

Healthcare decision-makers play a critical role in shaping patient access and coverage decisions. This webinar explains how the Cencora team partners with healthcare decision-makers to gather perspectives through structured market research and what to expect if you choose to participate as a panel member. 

We will cover the common research formats you may be invited to join (eg, surveys, in-depth interviews, advisory boards), the topics typically explored in market access research, and how participation fits into your schedule. You’ll also get an inside look at the participant experience, from registration and qualification to fair market value (FMV) determination, study invitations, scheduling, participation, and honoraria timelines.

Learning objectives:

  • Identify the common types of market access research formats offered to healthcare decision-makers and understand what participation typically involves for each format (eg, time commitment, preparation, and engagement style).
  • Explain the end-to-end process for becoming a panel member with Cencora including registration, qualification, and fair market value (FMV) determination.
  • Understand expectations for timing and communication when market research opportunities become available (study invitations, scheduling, participation, and honoraria processing).  

Live Q&A will be available, and attendees may submit questions anonymously.

Speakers

Moderator

Tasmina Hydery, PharmD, MBA, BCGP, FAMCP
Director, Value, Evidence, and Access, Cencora

Panelist

Emily Liu, MBA
Director, Value & Access Strategy, Cencora

Panelist

Sarah Dunlap, BS
Associate Director, FormularyDecisions, Cencora

Wir sind hier, um zu helfen

Setzen Sie sich noch heute mit unserem Team in Verbindung, um mehr darüber zu erfahren, wie Cencora die Zukunft des Gesundheitswesens mitgestaltet.

Verwandte Ressourcen

Artikel

Welt-WPA-Kongress 2026: Wichtige Marktzugangsthemen aus Amsterdam

Artikel

Vermeidung häufiger Fallstricke bei der frühen Kommerzialisierungsplanung

Webinar

Retain, release, reignite: Models to optimize the mature product portfolio